Evidence map›Paper›PMID 33595768›Full record

ReviewGeroScience2021

Cell-to-cell variation in gene expression and the aging process.

Alexander R Mendenhall, George M Martin, Matt Kaeberlein, Rozalyn M Anderson

Abstract readReview
In one paragraph

Review in GeroScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Stochasticity in Dietary Restriction-Mediated Lifespan Outcomes inbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexander R MendenhallDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA. alexworm@uw.edu.ORCID http://orcid.org/0000-0002-4716-7671
George M MartinDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
Matt KaeberleinDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA.
Rozalyn M AndersonDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin and Geriatric Research Education and Clinical Center, William S Middleton Memorial Veterans Hospital, Madison, WI, USA. rozalyn.anderson@wisc.edu.

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI GRABOWSKI, THOMAS J. · 1985 to 2019
$57.2M
XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Nicole Ann Errett · 1995 to 2026
$42.5M
University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Maitreya J Dunham · 1995 to 2026
$27.1M
International Registry of Werner SyndromeR01CA210916 · NCI · UNIVERSITY OF WASHINGTON · PI JUNKO OSHIMA · 2016 to 2026
$3.8M
Acetyl-CoA flux and mitochondrial adaptation: a pathogenic role in aging and AD?RF1AG057408 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, ROZALYN M., PUGLIELLI, LUIGI · 2017 to 2017
$3.5M
Metabolism of Alzheimer’s Disease: systems and cellular networksR01AG067330 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, ROZALYN M. · 2020 to 2024
$3.4M
Understanding the antagonistic role of proteostasis in Alzheimer disease and cancer.R01CA219460 · NCI · UNIVERSITY OF WASHINGTON · PI MENDENHALL, ALEXANDER RICHARD · 2018 to 2022
$2.2M
Adiponectin signaling in sarcopenia development and treatmentI01BX003846 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI ANDERSON, ROZALYN M. · 2018 to 2023
–
BLRD VA I01 BX003846NCI NIH HHS R01 CA210916NCI NIH HHS R01CA210916NCI NIH HHS R01 CA219460NCI NIH HHS R01CA219460NIA NIH HHS P30 AG013280NIA NIH HHS P30AG013280NIA NIH HHS P50AG005136NIA NIH HHS R01AG047358NIA NIH HHS R01 AG067330NIA NIH HHS RF1 AG057408NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

There is tremendous variation in biological traits, and much of it is not accounted for by variation in DNA sequence, including human diseases and lifespan. Emerging evidence points to differences in the execution of the genetic program as a key source of variation, be it stochastic variation or programmed variation. Here we discuss variation in gene expression as an intrinsic property and how it could contribute to variation in traits, including the rate of aging. The review is divided into sections describing the historical context and evidence to date for nongenetic variation, the different approaches that may be used to detect nongenetic variation, and recent findings showing that the amount of variation in gene expression can be both genetically programmed and epigenetically controlled. Finally, we present evidence that changes in cell-to-cell variation in gene expression emerge as part of the aging process and may be linked to disease vulnerability as a function of age. These emerging concepts are likely to be important across the spectrum of biomedical research and may well underpin what we understand as biological aging.

Indexed as

AgingLongevityGene ExpressionHumansPhenotypeAgingCell-to-cellEpigeneticsGene expressionHeterogeneityLifespanNongeneticStochasticSystems biology

Identifiers

PMID33595768
PMCPMC8050212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.